P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 198 400 KRW -0.8% Market Closed
Market Cap: 2.1T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note
PharmaResearch Co Ltd
/
Balance Sheet
/
Total Equity

PharmaResearch Co Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PharmaResearch Co Ltd
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
Total Equity
₩480.8B
CAGR 3-Years
21%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Total Equity
₩17T
CAGR 3-Years
67%
CAGR 5-Years
45%
CAGR 10-Years
31%
SK Bioscience Co Ltd
KRX:302440
Total Equity
₩1.7T
CAGR 3-Years
86%
CAGR 5-Years
51%
CAGR 10-Years
N/A
Green Cross Corp
KRX:006280
Total Equity
₩1.3T
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
4%
H
Hugel Inc
KOSDAQ:145020
Total Equity
₩817.1B
CAGR 3-Years
1%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Total Equity
₩185.7B
CAGR 3-Years
2%
CAGR 5-Years
24%
CAGR 10-Years
N/A
No Stocks Found

PharmaResearch Co Ltd
Glance View

Market Cap
2T KRW
Industry
Biotechnology

PharmaResearch Co., Ltd. engages in the research and development of refined raw materials for cell and tissue regeneration through marine bio technology. The company is headquartered in Gangneung, Gangwon-Do. The company went IPO on 2015-07-24. The firm produces and sells regenerated products such as pharmaceuticals, medical devices, and cosmetics. In addition, the Company is involved in the venture investment and real estate leasing. The firm mainly provides its products in domestic market.

Intrinsic Value
248 805.39 KRW
Undervaluation 20%
Intrinsic Value
Price
P
What is Intrinsic Value?

See Also

What is PharmaResearch Co Ltd's Total Equity?
Total Equity
480.8B KRW

Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's Total Equity amounts to 480.8B KRW.

What is PharmaResearch Co Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
19%

Over the last year, the Total Equity growth was 24%. The average annual Total Equity growth rates for PharmaResearch Co Ltd have been 21% over the past three years , 19% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 201,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.